EUDA — EUDA Health Holdings Income Statement
0.000.00%
Last trade - 00:00
- $47.33m
- $50.16m
- $9.84m
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 8.88 | 10.5 | 9.84 |
Cost of Revenue | |||
Gross Profit | 3.89 | 4.24 | 3.35 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Total Operating Expenses | 9.66 | 11.8 | 21.9 |
Operating Profit | -0.78 | -1.23 | -12 |
Total Net Non Operating Interest Income / Expense | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 0.246 | 0.949 | -24.9 |
Provision for Income Taxes | |||
Net Income After Taxes | 0.199 | 0.9 | -24.9 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | 0.176 | 0.865 | -24.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 0.176 | 0.865 | -24.9 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 0.003 | 0.029 | -0.8 |
Dividends per Share |